Trial Profile
A Phase Ib, Randomised, Placebo-Controlled, Double-Blind Study to Evaluate Potential Benefits of Two Concentrations of Betahistine Dihydrochloride Spray Administered as a Single Intranasal Dose in Adult Male and Female Volunteers with Eustachian Tube Dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Betahistine (Primary)
- Indications Meniere's disease; Otitis; Vertigo
- Focus Pharmacodynamics
- Sponsors Otifex Therapeutics
- 31 Jul 2015 New trial record